agomelatine +pharma 25 mg tabletki powlekane
+pharma arzneimittel gmbh - agomelatinum - tabletki powlekane - 25 mg
melatonina pharma nord 3 mg tabletki powlekane
pharma nord aps - melatoninum - tabletki powlekane - 3 mg
fingolimod +pharma 0,5 mg kapsułki twarde
+pharma arzneimittel gmbh - fingolimodum - kapsułki twarde - 0,5 mg
levosimendan mercapharm 2,5 mg/ml koncentrat do sporządzania roztworu do infuzji
mercapharm sp. z o.o. - levosimendanum - koncentrat do sporządzania roztworu do infuzji - 2,5 mg/ml
ibuprofen galpharm 200 mg tabletki powlekane
galpharm healthcare limited - ibuprofenum - tabletki powlekane - 200 mg
ibuprofen galpharm 400 mg tabletki powlekane
galpharm healthcare limited - ibuprofenum - tabletki powlekane - 400 mg
oxytocin panpharma 5 iu/ml koncentrat do sporządzania roztworu do infuzji
panpharma - oxytocin - koncentrat do sporządzania roztworu do infuzji - 5 iu/ml
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Środki przeciwnowotworowe - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
paracetamol + ibuprofen mercapharm (10 mg + 3 mg)/ml roztwór do infuzji
mercapharm sp. z o.o. - paracetamol + ibuprofen sodowy dwuwodny - roztwór do infuzji - (10 mg + 3 mg)/ml
loratadine galpharm 10 mg tabletki
galpharm healthcare limited - loratadinum - tabletki - 10 mg